- Fund Type: ETF
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Japan
Daiwa ETF TOPIX-17 Pharmaceutical
+ Add to Watchlist1638:JP
13,850.0000 JPY 250.0000 1.77%As of 00:38:59 ET on 05/24/2013.
Snapshot for Daiwa ETF TOPIX-17 Pharmaceutical (1638)
| Open: | 14,070.0000 | High - Low: | 14,070.0000 - 13,850.0000 | Primary Exchange: | Tokyo |
|---|---|---|---|---|---|
| Volume: | 452 | 52-Week Range: | 9,320.0000 - 15,480.0000 | Beta vs TP17PHRM: | 0.8754 |
Fund Profile & Information for 1638
Daiwa ETF TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated i n Japan. The objective of the Fund is to provide investment results that c orrespond to the performance of the TOPIX-17 Pharmaceutical Index.
| Inception Date: | 2008-07-23 | Telephone: | - |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.daiwa-am.co.jp | ||
Fundamentals for 1638
| NAV | (on 2013-05-24) 14,066.0000 |
|---|---|
| Assets (M) | (on 2013-05-24) 397.0000 |
| Shares out (M) | 0.03 |
| Market Cap (M) | 390.92 |
| % Premium | -1.54 |
| Average 52-Week % Premium | -0.2755 |
| Fund Leveraged | N |
Dividends for 1638
| Dividend Type | Distribution |
|---|---|
| Dividend Frequency | Semi-Anl |
| Last Dividend Net | (on 2013-01-16) 172.0000 |
| Dividend Yield (ttm) | 2.50% |
Performance for 1638
| 1-Month | -8.28% | 1-Year | +52.50% |
|---|---|---|---|
| 3-Month | +8.37% | 3-Year | +15.48% |
| Year To Date | +29.88% | 5-Year | - |
| Expense Ratio | 0.18 |
Top Fund Holdings for 1638
Filing Date: 04/30/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Takeda Pharmaceutical Co Ltd | 20,500 | 109,675,000 | 25.765% |
| Astellas Pharma Inc | 12,100 | 68,607,000 | 16.117% |
| Otsuka Holdings Co Ltd | 10,800 | 37,908,000 | 8.905% |
| Daiichi Sankyo Co Ltd | 17,100 | 32,575,500 | 7.653% |
| Eisai Co Ltd | 6,700 | 29,781,500 | 6.996% |
| Shionogi & Co Ltd | 8,000 | 19,184,000 | 4.507% |
| Ono Pharmaceutical Co Ltd | 2,700 | 17,334,000 | 4.072% |
| Chugai Pharmaceutical Co Ltd | 6,300 | 15,290,100 | 3.592% |
| Hisamitsu Pharmaceutical Co In | 1,700 | 9,741,000 | 2.288% |
| Taisho Pharmaceutical Holdings | 1,300 | 9,386,000 | 2.205% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page